Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Giro d’Italia Cyclist Tests Positive for Banned Stimulant

Don't Miss Out —
Follow us on:

May 15 (Bloomberg) -- French rider Sylvain Georges tested positive for a banned stimulant at the Giro d’Italia, cycling’s ruling body said.

The 29-year-old, who is on the AG2R-La Mondiale team, tested for the drug heptaminol -- which widens blood vessels -- in a urine sample on May 10, the Union Cycliste Internationale said in a statement.

Georges isn’t automatically suspended given the nature of the substance and can request analysis of a back-up sample, the UCI said. He was 109th of 193 riders in the race classification before today’s 11th stage.

He didn’t start the stage, Gazzetta dello Sport’s website reported. The Giro is the most prestigious stage race in cycling after the Tour de France.

Georges is in his third year as a professional and won a Tour of California stage last year.

Separately, the UCI said it suspended Miguel Ubeto after he tested positive for metabolic modulator GW1516 in an out-of-competition test last month.

Venezuela’s Ubeto, 36, races for the Lampre-Merida team.

To contact the reporters on this story: Alex Duff in Madrid at aduff4@bloomberg.net.

To contact the editor responsible for this story: Christopher Elser at at celser@bloomberg.net